Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
DescriptionLife Sciences Venture Firm



Wayne, USA
1400 Liberty Ridge Drive
Suite 103
Wayne, PA, 19087


General Partner
General Partner
General Partner


Devon Park BioVentures

Devon Park Bioventures is a venture capital fund targeting investments in therapeutics companies and, in certain cases, medical device, diagnostic and drug discovery technology companies.

Recent Milestones


Company Date Round Size Participants
ZS Pharma 3/2014Series D$55M9
Inotek Pharmaceuticals 9/2013Debt$7M6
MicuRx Pharmaceuticals 8/2013Series B$25M3
ZS Pharma 10/2012Series C$46M6
Vascular Magnetics 2/2012Series A$7M1
Inotek Pharmaceuticals 7/2011Series D$23.6M5
Cara Therapeutics 7/2010Series D$15M8
Cempra 6/2009Series C$46M6
Proteon Therapeutics 5/2009Series B$50M8



  1. ZS Pharma Completes $55 Million Financing to Advance Its Novel Investigational Treatment for Hyperkalemia ( [edit]
  2. Inotek Pharmaceuticals Raises $21 Million to Support Ongoing Clinical Development of Trabodenoson, a Novel Eye Drop for the Treatment of Glaucoma ( [edit]
  3. MicuRx Pharmaceuticals raises $25m in Series B financing ( [edit]
  4. ZS Pharma lands $46 million for kidney and liver drug development ( [edit]
  5. Venture backer makes $7M bet on cardio drug tech that could rival stents ( [edit]
  6. SEC ( [edit]
  7. Cara rounds up $15M for post-op pain drug Read more: Cara rounds up $15M for post-op pain drug ( [edit]
  8. Cempra Pharmaceuticals, Inc.: Series C $46M ( [edit]
  9. Proteon Therapeutics Completes Second Closing of Equity Financing ( [edit]
Edit This Page
Last Edited 3/5/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy